Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4795253
Max Phase: Preclinical
Molecular Formula: C26H26N2O8S3
Molecular Weight: 590.70
Molecule Type: Unknown
Associated Items:
ID: ALA4795253
Max Phase: Preclinical
Molecular Formula: C26H26N2O8S3
Molecular Weight: 590.70
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)c1ccc(S(=O)(=O)N(c2ccc3c(c2)N(S(C)(=O)=O)CCC3)S(=O)(=O)c2ccc(C(C)=O)cc2)cc1
Standard InChI: InChI=1S/C26H26N2O8S3/c1-18(29)20-7-12-24(13-8-20)38(33,34)28(39(35,36)25-14-9-21(10-15-25)19(2)30)23-11-6-22-5-4-16-27(26(22)17-23)37(3,31)32/h6-15,17H,4-5,16H2,1-3H3
Standard InChI Key: JFEVMHYDPVBRGT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 590.70 | Molecular Weight (Monoisotopic): 590.0851 | AlogP: 3.39 | #Rotatable Bonds: 8 |
Polar Surface Area: 143.04 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.26 | CX LogD: 2.26 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.36 | Np Likeness Score: -0.96 |
1. Dai Z,Chen XY,An LY,Li CC,Zhao N,Yang F,You ST,Hou CZ,Li K,Jiang C,You QD,Di B,Xu LL. (2021) Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis., 64 (1.0): [PMID:33332136] [10.1021/acs.jmedchem.0c01924] |
Source(1):